Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia

被引：0
|
作者：
Ben-Hamadi, R
Duh, MS
Aggarwal, J
Henckler, A
McKenzie, S
Fastenau, J
Piech, CT
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Ortho Biotech Clin Affairs LLC, Dallas, TX USA
[3] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62574-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [41] Cost and effectiveness of darbepoetin ALFA administered every 3 weeks (Q3W DA) compared with weekly epoetin ALFA (QW EA) or epoetin beta (QW EB) in patients (PTS) with chemotherapy-induced anemia (CIA): A retrospective study
    Coiffier, Bertrand
    Schlag, Rudolf
    Velasco, Amalia
    Yao, Bin
    Schupp, Marco
    Demarteau, Nadia
    Annemans, Lieven
    ANNALS OF ONCOLOGY, 2006, 17 : 293 - 293
  • [42] Darbepoetin alfa for chemotherapy-induced anemia: evolution to extended dosing intervals
    Vansteenkiste, Johan
    Wauters, Isabelle
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (10) : 1347 - 1355
  • [43] Darbepoetin alfa for the treatment of chemotherapy-induced anemia in patients with solid tumors
    Bustos, A.
    Carabantes, F.
    Alvarez, R.
    Diaz, N.
    Bueso, P.
    Lazaro, M.
    Gasquet, J. A.
    Alegre, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 197 - 197
  • [44] Efficacy of darbepoetin alfa in chemotherapy-induced anemia in gastrointestinal cancers.
    Blayney, D
    Vadhan-Raj, S
    Tomita, D
    Rossi, G
    Mirtsching, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 781S - 781S
  • [45] CHEMOTHERAPY-INDUCED ANEMIA MANAGEMENT WITH DARBEPOETIN ALFA IN DAILY CLINICAL PRACTICE
    Cruz, M. A.
    Bustos, A.
    Carabantes, F.
    Diaz, N.
    Rovira, P. Sanchez
    Froilan, J.
    Lorenzo, I.
    Gasquet, J. A.
    Alegre, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 284 - 284
  • [46] Evaluation of clinical use of darbepoetin alfa in patients with chemotherapy-induced anemia
    Bustos, A.
    Cruz, M. A.
    Aramburo, P.
    Carabantes, F.
    Diaz, N.
    Florian, J.
    Lazaro, M.
    Martin de Segovia, J. M.
    Gasquet, J. A.
    Alegre, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL
    Pirker, Robert
    Hedenus, Michael
    Vansteenkiste, Johan
    Hernandez, Enrique
    Belton, Laura
    Terwey, Jan-Henrik
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 122 - 135
  • [48] Effectiveness of darbepoetin alfa administered every three weeks to elderly patients with chemotherapy-induced anemia
    Gasent, J. M.
    Bermejo, J. C., II
    Lopez, P.
    Domenech, M.
    Sanchez-Rovira, P.
    Villadiego, K.
    de Pedro, C.
    Iturralde, P.
    Gasquet, J. A.
    Rodriguez, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Darbepoetin alfa in chemotherapy - Induced anemia treatment
    Grangeia, Luis
    da Cunha, Marinho
    Baptista, Ana
    Aroso, Manuela
    Moura, Antonio
    Mesquita, Teresa
    ANNALS OF ONCOLOGY, 2006, 17 : 303 - 304
  • [50] Cost-effectiveness analysis favors epoetin alfa to front-loaded regimens of darbepoetin alfa and dominates every other week dosing of darbepoetin alfa.
    Frame, D
    Fastenau, JM
    Piech, CT
    BLOOD, 2003, 102 (11) : 511B - 511B
12345